251 related articles for article (PubMed ID: 2393266)
1. Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.
Schinazi RF; Sommadossi JP; Saalmann V; Cannon DL; Xie MY; Hart GC; Smith GA; Hahn EF
Antimicrob Agents Chemother; 1990 Jun; 34(6):1061-7. PubMed ID: 2393266
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide dimers suppress HIV expression in vitro.
Busso M; Mian AM; Hahn EF; Resnick L
AIDS Res Hum Retroviruses; 1988 Dec; 4(6):449-55. PubMed ID: 2464362
[TBL] [Abstract][Full Text] [Related]
3. Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virus.
Zhou XJ; Squires K; Pan-Zhou XR; Bernhard S; Agrofoglio L; Kirk M; Duchin KL; Sommadossi JP
J Clin Pharmacol; 1997 Mar; 37(3):201-13. PubMed ID: 9089422
[TBL] [Abstract][Full Text] [Related]
4. Comparative metabolism of the antiviral dimer 3'-azido-3'-deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes.
Pan-Zhou XR; Cretton-Scott E; Zhou XJ; Xie MY; Rahmani R; Schinazi RF; Duchin K; Sommadossi JP
Antimicrob Agents Chemother; 1997 Nov; 41(11):2502-10. PubMed ID: 9371357
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activities of nucleotide heterodimers against human immunodeficiency virus type 1 in vitro.
Ijichi K; Fujiwara M; Mori K; Morozumi M; Machida H; Shigeta S; Konno K; Yokota T; Baba M
Antiviral Res; 1996 Jun; 31(1-2):115-20. PubMed ID: 8793015
[TBL] [Abstract][Full Text] [Related]
6. 5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile.
Daluge SM; Purifoy DJ; Savina PM; St Clair MH; Parry NR; Dev IK; Novak P; Ayers KM; Reardon JE; Roberts GB
Antimicrob Agents Chemother; 1994 Jul; 38(7):1590-603. PubMed ID: 7526782
[TBL] [Abstract][Full Text] [Related]
7. Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells.
Dornsife RE; St Clair MH; Huang AT; Panella TJ; Koszalka GW; Burns CL; Averett DR
Antimicrob Agents Chemother; 1991 Feb; 35(2):322-8. PubMed ID: 1708977
[TBL] [Abstract][Full Text] [Related]
8. Differential antiviral activities and intracellular metabolism of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in human cells.
Mukherji E; Au JL; Mathes LE
Antimicrob Agents Chemother; 1994 Jul; 38(7):1573-9. PubMed ID: 7526781
[TBL] [Abstract][Full Text] [Related]
9. Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro.
Mathez D; Schinazi RF; Liotta DC; Leibowitch J
Antimicrob Agents Chemother; 1993 Oct; 37(10):2206-11. PubMed ID: 7504908
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
[TBL] [Abstract][Full Text] [Related]
12. Response of Ethiopian human immunodeficiency virus type 1 isolates to antiviral compounds.
Wondimu Z; Sönnerborg A; Ayehunie S; Britton S; Strannegård O
Antiviral Res; 1992 Oct; 19(4):353-9. PubMed ID: 1281393
[TBL] [Abstract][Full Text] [Related]
13. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
[TBL] [Abstract][Full Text] [Related]
14. Effect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytes.
Mercure L; Brenner BJ; Phaneuf D; Tsoukas C; Wainberg MA
Antimicrob Agents Chemother; 1994 May; 38(5):986-90. PubMed ID: 8067781
[TBL] [Abstract][Full Text] [Related]
15. Uridine reverses the toxicity of 3'-azido-3'-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity.
Sommadossi JP; Carlisle R; Schinazi RF; Zhou Z
Antimicrob Agents Chemother; 1988 Jul; 32(7):997-1001. PubMed ID: 3190201
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2'3'-dideoxyadenosine (DDA) and 3'-azido-3'-deoxythymidine (AZT).
Chang SL; Griesgraber G; Wagner CR
Nucleosides Nucleotides Nucleic Acids; 2001 Aug; 20(8):1571-82. PubMed ID: 11554546
[TBL] [Abstract][Full Text] [Related]
17. Differential toxicity of carbovir and AZT to human bone marrow hematopoietic progenitor cells in vitro.
Kurtzberg J; Carter SG
Exp Hematol; 1990 Nov; 18(10):1094-6. PubMed ID: 2209763
[TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
[TBL] [Abstract][Full Text] [Related]
19. 2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activity.
Bhalla K; Birkhofer M; Li GR; Grant S; MacLaughlin W; Cole J; Graham G; Volsky DJ
Blood; 1989 Nov; 74(6):1923-8. PubMed ID: 2572282
[TBL] [Abstract][Full Text] [Related]
20. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
